Literature DB >> 3159474

Defective facilitated diffusion of nucleosides, a primary mechanism of resistance to 5-fluoro-2'-deoxyuridine in the HCT-8 human carcinoma line.

A F Sobrero, R D Moir, J R Bertino, R E Handschumacher.   

Abstract

In vitro resistance of HCT-8 cells to 5-fluoro-2'-deoxyuridine (FdUrd) has been obtained after a stepwise increase (up to 1 microM) in the concentration of the nucleoside in the culture medium over a period of 6 months. With a clonogenic assay, the toxicities of 17 antineoplastic agents on HCT-8-sensitive and -resistant cells were compared. Resistant cells were 700-fold resistant to FdUrd and showed different degrees of cross-resistance to several purine and pyrimidine nucleoside analogues; no cross-resistance was noted to base analogues and other cytotoxic drugs. The activities of FdUrd phosphorylase, 5'-fluorouridine kinase, 5-fluorouridine phosphorylase, 5-fluorouracil phosphoribosyltransferase, and thymidylate synthase were not significantly different in the sensitive and resistant cell lines. Mixing experiments indirectly excluded the possible elevation of the level of cytoplasmic phosphatases. The activity of FdUrd kinase in sensitive cell extracts was no more than twice that of resistant cells, and the affinities of this enzyme for FdUrd and thymidine at 0.1 to 50 microM were similar in both cell lines. However, cultures of this line failed to accumulate 5-fluoro-2'-deoxyuridylate at concentrations of FdUrd that resulted in substantial accumulation of the nucleotide in the sensitive line. These contrasting data suggested a defect in the facilitated diffusion of the analogue. The entrance of free nucleoside and its subsequent phosphorylation were compared in the two lines over short (2 to 40 s) and longer time periods at 25 degrees C and at 4 degrees C over a range of extracellular FdUrd concentrations (0.1 to 10 microM). Rapid entrance of the nucleoside into sensitive cells was observed, but entry was not detectable in resistant cells. Dipyridamole and nitrobenzylthioinosine inhibition as well as high-performance liquid chromatography analysis confirmed that data obtained from the sensitive cell line during the first 40 s primarily reflected facilitated diffusion of free nucleoside.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3159474

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  10 in total

1.  In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Authors:  Y Sugimoto; Y Ohe; K Nishio; T Ohmori; Y Fujiwara; N Saijo
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Membrane transport and the antineoplastic action of nucleoside analogues.

Authors:  F M Sirotnak; J R Barrueco
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

3.  Recombinant interferon-gamma primes alveolar macrophages cultured in vitro for the release of leukotriene B4 in response to IgG stimulation.

Authors:  J A Rankin; C E Schrader; S M Smith; R A Lewis
Journal:  J Clin Invest       Date:  1989-05       Impact factor: 14.808

4.  Tumor trapping of 5-fluorouracil: in vivo 19F NMR spectroscopic pharmacokinetics in tumor-bearing humans and rabbits.

Authors:  W Wolf; C A Presant; K L Servis; A el-Tahtawy; M J Albright; P B Barker; R Ring; D Atkinson; R Ong; M King
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

5.  Effects of oxaliplatin and CPT-11 on cytotoxicity and nucleic acid incorporation of the fluoropyrimidines.

Authors:  Manish Patel; Ram Agarwal; Bach Ardalan
Journal:  J Cancer Res Clin Oncol       Date:  2004-06-15       Impact factor: 4.553

6.  Evaluation of plasma 5-fluorouracil nucleoside levels in patients with metastatic breast cancer: relationships with toxicities.

Authors:  M Barberi-Heyob; B Weber; J L Merlin; C Dittrich; E A de Bruijn; E Luporsi; F Guillemin
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.

Authors:  F M Muggia; K K Chan; C Russell; N Colombo; J L Speyer; K Sehgal; S Jeffers; J Sorich; L Leichman; U Beller
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333

Review 8.  Nucleoside salvage and resistance to antimetabolite anticancer agents.

Authors:  M Fox; J M Boyle; A R Kinsella
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

9.  Potentiation of methotrexate lymphocytotoxicity in vitro by inhibitors of nucleoside transport.

Authors:  J M Hughes; M H Tattersall
Journal:  Br J Cancer       Date:  1989-03       Impact factor: 7.640

10.  Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells.

Authors:  M Inaba; J Mitsuhashi; H Sawada; N Miike; Y Naoe; A Daimon; K Koizumi; H Tsujimoto; M Fukushima
Journal:  Jpn J Cancer Res       Date:  1996-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.